Boston Scientific To Participate In Citi 2017 Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as Big Tech earnings rekindle AI spending worries; oil hits $100
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Boston Scientific (BSX) PT Lowered to $30 at Stifel Following Lotus Delay
November 29, 2017 1:42 PM ESTStifel lowered its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $32.00) while maintaining a Buy rating following the company's confirmation of another Lotus EDGE (TAVR) US/EU delay.
On this mornings call, BSX reaffirmed a strong commitment to Lotus, although... More
